Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Witschi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Organic Letters|August 31, 2010
Selective acetylation of per-O-TMS-protected monosaccharidesMark A Witschi, Jacquelyn Gervay-Hague
Methods in Enzymology|August 30, 2006
Peptide nucleic acid microarrays made with (S,S)-trans-cyclopentane-constrained peptide nucleic acidsMark A Witschi, Jonathan K Pokorski, Daniel H Appella
Journal of the American Chemical Society|December 21, 2006
PNA-DNA duplexes, triplexes, and quadruplexes are stabilized with trans-cyclopentane unitsEthan A Englund, Qun Xu, Mark A Witschi, et al.
Journal of the American Chemical Society|November 19, 2004
(S,S)-trans-cyclopentane-constrained peptide nucleic acids. a general backbone modification that improves binding affinity and sequence specificityJonathan K Pokorski, Mark A Witschi, Bethany L Purnell, et al.
The Journal of Organic Chemistry|August 29, 2013
Regioselective silyl/acetate exchange of disaccharides yields advanced glycosyl donor and acceptor precursorsHsiao-Wu Hsieh, Matthew W Schombs, Mark A Witschi, et al.
Neoplasia (New York, N.Y.)|May 3, 2011
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancerYanning Liu, John T Norton, Mark A Witschi, et al.
Organic Letters|July 19, 2003
A cyclopentane conformational restraint for a peptide nucleic acid: design, asymmetric synthesis, and improved binding affinity to DNA and RNAMichael C Myers, Mark A Witschi, Nataliya V Larionova, et al.
Anti-Cancer Drugs|November 29, 2007
Synthesis and anticancer activities of 6-amino amonafide derivativesJohn T Norton, Mark A Witschi, Lynn Luong, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Organic Letters|August 31, 2010
Selective acetylation of per-O-TMS-protected monosaccharidesMark A Witschi, Jacquelyn Gervay-Hague
Methods in Enzymology|August 30, 2006
Peptide nucleic acid microarrays made with (S,S)-trans-cyclopentane-constrained peptide nucleic acidsMark A Witschi, Jonathan K Pokorski, Daniel H Appella
Journal of the American Chemical Society|December 21, 2006
PNA-DNA duplexes, triplexes, and quadruplexes are stabilized with trans-cyclopentane unitsEthan A Englund, Qun Xu, Mark A Witschi, et al.
Journal of the American Chemical Society|November 19, 2004
(S,S)-trans-cyclopentane-constrained peptide nucleic acids. a general backbone modification that improves binding affinity and sequence specificityJonathan K Pokorski, Mark A Witschi, Bethany L Purnell, et al.
The Journal of Organic Chemistry|August 29, 2013
Regioselective silyl/acetate exchange of disaccharides yields advanced glycosyl donor and acceptor precursorsHsiao-Wu Hsieh, Matthew W Schombs, Mark A Witschi, et al.
Neoplasia (New York, N.Y.)|May 3, 2011
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancerYanning Liu, John T Norton, Mark A Witschi, et al.
Organic Letters|July 19, 2003
A cyclopentane conformational restraint for a peptide nucleic acid: design, asymmetric synthesis, and improved binding affinity to DNA and RNAMichael C Myers, Mark A Witschi, Nataliya V Larionova, et al.
Anti-Cancer Drugs|November 29, 2007
Synthesis and anticancer activities of 6-amino amonafide derivativesJohn T Norton, Mark A Witschi, Lynn Luong, et al.
Pageof 1